FILE PHOTO: A woman from Beijing receives an injection of the Gardasil 9 human papillomavirus (HPV) vaccine, which, according to local media, is the first in mainland China, at a hospital in Boao, Hainan province, China May 30, 2018. REUTERS/StringerMore

By Ankur Banerjee

(Reuters Health) – – Young women who received human papillomavirus (HPV) vaccines as adolescents had significantly lower rates of a condition that’s a precursor to cervical cancer, in a nationwide study in Scotland.

“The magnitude of the effect is greater than expected,” study author Dr. Tim Palmer from the University of Edinburgh told Reuters Health by email.

Receiving three doses of the vaccine at the recommended ages of 12 to 13 was associated with “a profound reduction of cervical disease seven years later,” he and

Read More At Article Source | Article Attribution